Covered recipient · General Payments record
BHAVESH SHAH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$9,586.41
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $255.61 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $91.92 | 4 |
| PFIZER INC. | $51.56 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $38.03 | 1 |
| Novo Nordisk AS | $36.17 | 2 |
| Amgen Inc. | $24.11 | 1 |
| Acerta Pharma LLC | $13.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $24.11 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111703020 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.82 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104396793 | CMS |
| Boston Scientific Corporation | $38.03 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092444632 | CMS |
| Lilly USA, LLC | $22.97 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136068762 | CMS |
| Lilly USA, LLC | $25.88 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136069596 | CMS |
| Lilly USA, LLC | $18.24 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136069008 | CMS |
| Lilly USA, LLC | $24.83 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136081006 | CMS |
| Novo Nordisk Inc | $14.87 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096621580 | CMS |
| Novo Nordisk Inc | $21.30 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097193691 | CMS |
| PFIZER INC. | $16.87 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130953494 | CMS |
| PFIZER INC. | $18.81 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131281356 | CMS |
| PFIZER INC. | $15.88 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131426127 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.